These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8117350)

  • 1. Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity.
    Lim SG; Sawyerr AM; Hudson M; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 1993 Jun; 7(3):317-21. PubMed ID: 8117350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oral antifungals and their clinical implications.
    Heykants J; Van Peer A; Lavrijsen K; Meuldermans W; Woestenborghs R; Cauwenbergh G
    Br J Clin Pract Suppl; 1990 Sep; 71():50-6. PubMed ID: 1965419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole.
    Kanda Y; Kami M; Matsuyama T; Mitani K; Chiba S; Yazaki Y; Hirai H
    Hematol Oncol; 1998 Mar; 16(1):33-7. PubMed ID: 9821410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The triazole antifungal agents: a review of itraconazole and fluconazole.
    Bailey EM; Krakovsky DJ; Rybak MJ
    Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.
    Van Peer A; Woestenborghs R; Heykants J; Gasparini R; Gauwenbergh G
    Eur J Clin Pharmacol; 1989; 36(4):423-6. PubMed ID: 2544431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of oral itraconazole in AIDS patients.
    Smith D; van de Velde V; Woestenborghs R; Gazzard BG
    J Pharm Pharmacol; 1992 Jul; 44(7):618-9. PubMed ID: 1357148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers.
    Barone JA; Koh JG; Bierman RH; Colaizzi JL; Swanson KA; Gaffar MC; Moskovitz BL; Mechlinski W; Van de Velde V
    Antimicrob Agents Chemother; 1993 Apr; 37(4):778-84. PubMed ID: 8388198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical pharmacokinetics of itraconazole: an overview.
    Heykants J; Van Peer A; Van de Velde V; Van Rooy P; Meuldermans W; Lavrijsen K; Woestenborghs R; Van Cutsem J; Cauwenbergh G
    Mycoses; 1989; 32 Suppl 1():67-87. PubMed ID: 2561187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole.
    Zimmermann T; Yeates RA; Laufen H; Pfaff G; Wildfeuer A
    Eur J Clin Pharmacol; 1994; 46(2):147-50. PubMed ID: 8039534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of itraconazole following oral administration to normal volunteers.
    Hardin TC; Graybill JR; Fetchick R; Woestenborghs R; Rinaldi MG; Kuhn JG
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1310-3. PubMed ID: 2848442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole.
    Vuddhakul V; Mai GT; McCormack JG; Seow WK; Thong YH
    Int J Immunopharmacol; 1990; 12(6):639-45. PubMed ID: 2177039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole antifungal drugs: old and new.
    Dismukes WE
    Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
    [No Abstract]   [Full Text] [Related]  

  • 14. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
    Tucker RM; Denning DW; Hanson LH; Rinaldi MG; Graybill JR; Sharkey PK; Pappagianis D; Stevens DA
    Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration.
    Schäfer-Korting M; Korting HC; Lukacs A; Heykants J; Behrendt H
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):211-5. PubMed ID: 2155951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects.
    Zimmermann T; Yeates RA; Albrecht M; Laufen H; Wildfeuer A
    Int J Clin Pharmacol Res; 1994; 14(3):87-93. PubMed ID: 7883389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
    Guinet R; Marlier H
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):575-8. PubMed ID: 2166937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicological profile and safety evaluation of antifungal azole derivatives.
    Van Cauteren H; Lampo A; Vandenberghe J; Vanparys P; Coussement W; De Coster R; Marsboom R
    Mycoses; 1989; 32 Suppl 1():60-6. PubMed ID: 2561186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.